Antivascular endothelial growth factor in hereditary dystrophies

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Choroidal neovascularization can rarely complicate the course of a number of chorioretinal hereditary dystrophies leading to an even further impaired vision function. In recent years, several case reports and case series have shown that intravitreal injections of antivascular endothelial growth factor drugs can be effective in treating subfoveal choroidal neovascularization secondary to chorioretinal dystrophies either improving vision, or at least halting its progressive loss. Additional studies are warranted to confirm the initial positive response and to assess the best therapeutic regimen.

Original languageEnglish
Title of host publicationAnti-VEGF
PublisherS. Karger AG
Pages107-110
Number of pages4
Volume46
ISBN (Print)9783805595308, 9783805595292
DOIs
Publication statusPublished - Aug 13 2010

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this